MLL4 is an essential subunit of the histone H3 Lys4 (H3K4)-methylation complexes. We found that MLL4 deficiency compromised the development of regulatory T cells (T reg cells) and resulted in a substantial decrease in monomethylated H3K4 (H3K4me1) and chromatin interaction at putative gene enhancers, a considerable portion of which were not direct targets of MLL4 but were enhancers that interacted with MLL4-bound sites. The decrease in H3K4me1 and chromatin interaction at the enhancers not bound by MLL4 correlated with MLL4 binding at distant interacting regions. Deletion of an upstream MLL4-binding site diminished the abundance of H3K4me1 at the regulatory elements of the gene encoding the transcription factor Foxp3 that were looped to the MLL4-binding site and compromised both the thymic differentiation and the inducible differentiation of T reg cells. We found that MLL4 catalyzed methylation of H3K4 at distant unbound enhancers via chromatin looping, which identifies a previously unknown mechanism for regulating the T cell enhancer landscape and affecting T reg cell differentiation.
Regulatory T cells (T reg cells) act as central participants in the establishment of homeostasis of the immune system by suppressing the activation, proliferation and effector functions of various immune cells 1 . They develop in the thymus from CD4 + single-positive (CD4SP) cells or differentiate from naive CD4 + T cells 2 . The cytokine TGF-β drives the differentiation of T reg cells by upregulating expression of the transcription factor Foxp3, which is necessary for suppressive activity and serves as a marker of T reg cells [3] [4] [5] . Deregulation of the development and function of T reg cells leads to autoimmune disease and immunopathology 1, [6] [7] [8] . Because of their important roles in numerous diseases, including allergy 9 , autoimmunity 1,6-8 , microbial infections 10 and cancer 11 , T reg cells have become a focus for the development of various therapies aiming at treating autoimmune disorders and graftversus-host disease 12, 13 . Thus, thorough understanding of the regulatory processes that govern T reg cell differentiation is necessary.
Cell specification is under the control of cell-specific gene enhancers. Foxp3 is the signature transcription factor that defines T reg cells; it is regulated by three distal enhancer elements-conserved noncoding sequences CNS1, CNS2 and CNS3-at different stages of T reg cell development 14 . The genome-wide enhancer landscape in T reg cells has been described 15 . Foxp3 does not establish a T reg cell-specific enhancer landscape but instead exploits previously established already existing enhancers 16 . However, the mechanisms that initially establish the enhancer landscape remain unclear.
Active and primed enhancers are characterized by the presence of permissive histone modifications such as histone acetylation and monomethylation of histone H3 Lys4 (H3K4me1) 17 . The activating histone marks facilitate the opening of chromatin and the recruitment of transcription factors and other regulatory machineries. The methylation of H3K4 is catalyzed by the MLL family of histone methyltransferases, which includes SETD1A, MLL1 (KMT2A) 18 , MLL2 (KMT2B), MLL3 (KMT2C) and MLL4 (KMT2D). MLL4 has been shown to shape enhancer patterns in mammalian cells during heart development 19 , myogenesis and adipogenesis 20 by regulating the mono-and dimethylation of H3K4.
We found that MLL4 served a critical requirement for T reg cell development by establishing the enhancer landscape and facilitating long-range chromatin interaction. We showed that in addition to regulating the monomethylation of H3K4 at direct binding sites, MLL4 catalyzed the methylation of H3K4 in trans at distant unbound enhancers via long-distance chromatin looping. This identifies a previously unrecognized mechanism for regulating the histone modification and enhancer landscape of cells.
RESULTS

Deletion of Mll4 results in compromised T reg cell development
To investigate the function of MLL4 in T cell development, we generated mice with conditional deficiency in MLL4 in CD4 + T cells A r t i c l e s by breeding mice that carry loxP sites flanking exons [16] [17] [18] [19] of Mll4 (Mll4 fl/fl mice) 20 with mice that express Cre recombinase from the T cell-specific Cd4 promoter (Cd4-Cre + mice). We analyzed Mll4 fl/fl Cd4-Cre -, Mll4 fl/fl Cd4-Cre + , Mll4 fl/+ Cd4-Cre + and Mll4 +/+ Cd4-Cre + mice as controls for the effect of the Cd4-Cre construct or partial deletion of Mll4 on mouse phenotypes. We confirmed efficient deletion of the loxP-flanked Mll4 exons in CD4 + T cells isolated from Mll4 fl/fl Cd4-Cre + mice and their partial deletion in Mll4 fl/+ Cd4-Cre + cells, by RT-PCR ( Supplementary Fig. 1a ), RNA-seq ( Supplementary  Fig. 1b ) and immunoblot analysis (Supplementary Fig. 1c ). Deletion of exons [16] [17] [18] [19] results in a truncated MLL4 protein and disrupts the MLL4 complex 20 . Because we confirmed that the Cd4-Cre transgene alone had no effect on the mouse phenotype and we did not observe significant differences among Mll4 fl/fl Cd4-Cre − , Mll4 fl/+ Cd4-Cre + and Mll4 +/+ Cd4-Cre + mice in their T cell populations ( Fig. 1 and  Supplementary Fig. 1d-g) , we call all three of these strains of mice 'wild-type' here (unless stated otherwise) and call Mll4 fl/fl Cd4-Cre + mice 'Mll4-KO' here.
Conditional deletion of Mll4 had no significant effect on T cell development in the thymus, as populations of CD4 + CD8 + double-positive cells, CD4 + single-positive (CD4SP) cells and CD8 + single-positive (CD8SP) cells remained similar in all groups of mice examined (Fig. 1a,b) ; however, it substantially decreased the frequency and total number of CD4 + Foxp3 + T reg cells in the thymus of Mll4-KO mice compared with the abundance of such cells in their wild-type littermates (Fig. 1c,d) . Deletion of Mll4 also significantly reduced the number of CD4 + and CD8 + T cells in secondary lymphoid organs, including the spleen (Fig. 1e,f) and lymph nodes ( Supplementary Fig. 1e,g) . Although the frequency of Foxp3 + cells within the CD4 + T cell population in spleen and lymph nodes was not substantially affected in Mll4-KO mice ( Fig. 1g and Supplementary Fig. 1f) , the total number of CD4 + Foxp3 + T cells was reduced ( Fig. 1h and Supplementary  Fig. 1g ) as a result of the decrease in the total CD4 + T cell population in these organs. Consistent with the preserved ratio of T reg cells to T eff cells after deletion of Mll4, we did not see an increase in the number of T cells producing interferon-γ (IFN-γ), interleukin 17A Figure 1 Mll4 deficiency reduces the number of T reg cells in the thymus and the number of T cells in the periphery. (a) Flow cytometry identifying CD4SP, CD8SP, CD4 − CD8 − and CD4 + CD8 + T cell populations in the thymus of Mll4 fl/fl Cd4-Cre -, Mll4 fl/fl Cd4-Cre + , Mll4 fl/+ Cd4-Cre + and Mll4 +/+ Cd4-Cre + mice (above plots). Numbers adjacent to outlined areas indicate percent cells in each throughout. (b) Frequency of CD4 + CD8 + (double-positive (DP)), CD4SP and CD8SP T cells among total cells in the thymus of mice as in a (below plots). (c) Flow cytometry identifying CD4SP Foxp3 + cells in the thymus of mice as in a (above plots). (d) Frequency of CD4SP Foxp3 + cells in the thymus of mice as in a (below plots). (e) Flow cytometry identifying CD4 + and CD8 + T cells in the spleen of mice as in a (above plots). (f) Quantification of total CD4 + T cells (top) and CD8 + T cells (bottom) in the spleen of mice as in a (below plots). (g) Flow cytometry identifying CD4 + Foxp3 + cells in the spleen of mice as in a (above plots). (h) Quantification of total CD4 + Foxp3 + cells in the spleen of mice as in a (below plots). Each symbol (b,d,f,h) represents an individual mouse; small horizontal lines indicate the mean (±s.d.). **P ≤ 0.01, ***P ≤ 0.001 and ****P ≤ 0.0001 (Kruskal-Wallis test). Data are from one experiment representative of n = 4 (a,c) or n = 5 (e,g) independent experiments or are representative of three experiments (b,d,f,h).
A r t i c l e s (IL-17A) ( Supplementary Fig. 2a-d ) or IL-4 (data not shown) in the spleen and lymph nodes of Mll4-KO mice compared with the abundance of such cells in wild-type mice. We also did not see a lower frequency of Foxp3 + cells within the CD4 + T cell population or aberrant cytokine production by T cells in the lungs of Mll4-KO mice (data not shown). However, we did find a significantly lower abundance of Foxp3 + cells among CD4 + T cells for leukocytes from the lamina propria of the small intestine of Mll4-KO mice compared with the abundance of such cells in their wild-type counterparts ( Fig. 2a,b) . Consequently, deletion of Mll4 led to an increase in the number of IL-17A-producing cells, which was probably due to the lower abundance of T reg cells in small intestine ( Fig. 2c,d) . T reg cells from in all organs examined of Mll4-KO mice showed a more activated phenotype, as defined by increased expression of the activation marker Ki67 ( Supplementary Fig. 2e and data not shown) and the transcription factor Helios 21 ( Supplementary Fig. 2f and data not shown). T reg cells isolated from spleen and lymph nodes of wild-type and Mll4-KO mice showed similar suppressive activity, as assessed by an in vitro suppression assay ( Supplementary Fig. 2g ), and had similar expression of T reg cell-associated markers such as CTLA-4, CD25 and GITR (data not shown), which suggested that MLL4 was not required for T reg cell function. To assess the effect of Foxp3-driven deletion of Mll4 on T reg cells, we generated Mll4 fl/fl Foxp3-Cre + mice by crossing Mll4 fl/fl mice 20 with mice that express yellow fluorescent protein (YFP)-tagged Cre from Foxp3 (Foxp3-CreYFP + mice) 22 . We confirmed the specificity and efficiency of the deletion of Mll4 in T reg cells from Mll4 fl/fl Foxp3-Cre + mice (Supplementary Fig. 3a ). Mll4 fl/fl Foxp3-Cre + mice exhibited a slight reduction in the frequency of T reg cells in the thymus and periphery relative to that of Mll4 +/+ Foxp3-Cre + mice ( Supplementary  Fig. 3b-e,g,h) , but this Foxp3-driven deletion of Mll4 had no effect on cytokine production by CD4 + T cells ( Supplementary Fig. 3f,i) .
An in vitro suppression assay demonstrated the normal functionality of T reg cells isolated from Mll4 fl/fl Foxp3-Cre + mice ( Supplementary  Fig. 3j ), which indicated that MLL4 had no effect on suppressive function in cells already expressing Foxp3. Together these data suggested that MLL4 regulated the development of T reg cells but not their function.
Induction of Foxp3 expression requires MLL4
To further understand the role of MLL4 in T reg cell development, we differentiated naive CD4 + T cells from wild-type and Mll4-KO mice into T reg cells in vitro (to generate inducible T reg cells (iT reg cells)). We found that the expression of Foxp3 by Mll4-KO CD4 + T cells was one fifth that of wild-type cells during differentiation into the iT reg cell lineage ( Fig. 2e) . At day 3 of differentiation, more than 70% of the CD4 + T cells from wild-type mice expressed Foxp3, while only 20% of the CD4 + T cells from Mll4-KO mice expressed Foxp3 (Fig. 2f) . Our results obtained by staining with the division-tracking dye CFSE indicated that Mll4-KO CD4 + T cells displayed a delay in proliferation and induction of Foxp3 expression compared with that of wild-type cells at early times; however, by day 4 of in vitro culture, both the proliferation and Foxp3 expression of Mll4-KO CD4 + T cells were similar to that of wild-type cells ( Supplementary Fig. 4a ), which indicated that the compromised Foxp3 expression was not caused by a defect in cell proliferation. These observations suggested a direct role for MLL4 in the induction of Foxp3 expression.
To investigate whether MLL4 has a role in maintaining Foxp3 expression, we first stimulated naive CD4 + T cells from Mll4 fl/fl mice for 24 h under T reg cell-inducting conditions and then infected the cells for 2 more days with retroviral vector expressing Cre recombinase or retrovirus expressing an empty vector. RT-PCR analysis confirmed the deletion of Mll4 exons 16-19 by the ** ** ** CD4-PerCpCy5.5 A r t i c l e s retrovirus-expressed Cre recombinase ( Fig. 3a) . We observed no difference in the number of Foxp3 + cells in cultures infected with retroviral vector expressing Cre relative to that in cultures infected with retrovirus expressing empty vector (Fig. 3b) ; this suggested that MLL4 was required only for the initiation of Foxp3 expression but was not required for its maintenance. Furthermore, Mll4 expression was much higher in naive CD4 + T cells than in effector cells of the T H 1, T H 2 and T H 17 subsets of helper T cells and iT reg cells induced in vitro (Fig. 3c,d) . Mll4 expression in thymic T reg cells was comparable to that in CD4SP cells in the thymus (Fig. 3e) . We also investigated whether deletion of Mll4 affected the differentiation of other effector T cells, including T H 1, T H 2 and T H 17 cells, under in vitro differentiation conditions. Only very modest changes were observed in expression of the transcription factor T-bet and IFN-γ under T H 1 conditions ( Supplementary Fig. 4b,c ) and in the expression of IL-17A and the transcription factor RORγ under T H 17 conditions ( Supplementary Fig. 4d,e ), while expression of the transcription factor GATA-3 and IL-4 was increased in T H 2 cell cultures after deletion of Mll4 ( Supplementary  Fig. 4f,g) . These observations indicated that MLL4 was dispensable for differentiation of the T H 1, T H 2 and T H 17 cell lineages in vitro. Together these data indicated that MLL4 was required for the induction but not the maintenance of Foxp3 expression during T reg cell development and had only minimal function in other effector T cells.
Mll4-KO
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MLL4 regulates the H3K4me1 landscape in naive CD4 + T cells MLL4 has been reported to regulate mainly the mono-and dimethylation of H3K4 (refs. 19,20,23) , although some early reports suggested that MLL4 also regulates its trimethylation 24, 25 . We found that deletion of Mll4 in T cells decreased the mono-or trimethylation of H3K4 only modestly, while we detected no substantial decrease in the dimethylation of H3K4 after deletion of Mll4 (Supplementary Fig.  5a ); this suggested that other H3K4-methylation enzymes were present in the cells. We found that the gene encoding MLL3, which is a close homolog of MLL4 and has functions partially redundant with those of MLL4 (ref. 20) , exhibited an expression pattern similar to that of Mll4 in CD4 + T cells ( Supplementary Fig. 5b ). Because naive CD4 + T cells expressed significantly more MLL4 than did iT reg cells and because the deletion of Mll4 at later stages of T reg cell differentiation in vitro had no effect on Foxp3 expression, we analyzed the MLL4-binding and H3K4me1-enrichment profiles of naive CD4 + T cells by chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq). Analysis of ChIP-Seq peaks by the SICER clustering algorithm 26 revealed that approximately 50% of the 16,161 MLL4 peaks were located in promoter regions of genes and the other half mapped to the gene body and intergenic regions called 'non-promoter peaks' (Supplementary Fig. 5c ). MLL4 bound predominantly to genomic regions that showed enrichment for H3K4me1, as exemplified by a 350-kilobase (kb) genomic region in the X chromosome ( Fig. 4a) . However, a large number of H3K4me1 peaks were not direct targets of MLL4 ( Fig. 4a) . Globally, while MLL4 bound to two thirds of the regions showing enrichment for H3K4me1 that overlapped the promoters, it was detected at less than 20% of the H3K4me1 peaks at other genomic regions ( Fig. 4b) . We relaxed the threshold by SICER 26 to call MLL4-binding sites step by step until the additionally called peaks from MLL4 ChIP-Seq were indistinguishable from the input control ( Supplementary Fig. 5d ). Even with the most relaxed criteria, we still observed that 50-60% of the H3K4me1 peaks at non-promoter regions were not bound by MLL4 (Supplementary Fig. 5e ).
Non-promoter genomic regions that showed enrichment for H3K4me1 ('H3K4me1-enriched') but were devoid of MLL4 binding ('MLL4-unbound') were linked to genes encoding products involved in T cell activation, as assessed by gene-ontology-enrichment analysis with the tool GREAT 27 (Supplementary Fig. 5f ), which suggested that these elements were involved in T cell differentiation and function. Genomic sequence analysis revealed that these sites were conserved in DNA sequence across mammalian species (Supplementary Fig. 5g ). Those H3K4me1-enriched MLL4-unbound regions were generally less accessible than MLL4-bound regions, as revealed by genome-wide sequencing of regions sensitive to DNase (DNase-Seq) 28 ( Fig. 4c and Supplementary Fig. 5h ). These results indicated that the chromatin environment of the H3K4me1-enriched MLL4-unbound regions were unfavorable for direct binding of MLL4 and suggested that the modulation of H3K4me1 in these regions by MLL4 might be achieved through mechanisms other than direct binding.
To identify H3K4me1 peaks affected by deletion of Mll4, we compared the H3K4me1 profiles of wild-type CD4 + T cells with those of Mll4-KO CD4 + T cells. As a specific example, deletion of Mll4 induced a substantial increase in H3K4me1 at the promoter region of Dynlt1f (which encodes a dynein light chain) and a decrease in H3K4me1 at putative enhancers bound by MLL4 ( Supplementary Fig. 6a,b) . Globally, we found that 13.5% of the MLL4-bound enhancers showed A r t i c l e s a decrease in H3K4me1 after deletion of Mll4, whereas only 1.2% showed an increase in H3K4me1 ( Supplementary Fig. 6c ), in support of the proposal of a direct role for MLL4 in regulating H3K4me1 at its binding sites 20 . Notably, deletion of Mll4 also substantially decreased H3K4me1 at enhancers without MLL4 binding, as exemplified by several putative enhancers upstream of Dynlt1f ( Supplementary  Fig. 6a ) and Cxcr4 (which encodes a chemokine receptor) ( Fig. 4d) . Of all the non-promoter regions that showed enrichment for H3K4me1 but were devoid of MLL4 binding, 14.8% exhibited a significant decrease in H3K4me1 after deletion of Mll4 (Supplementary Fig. 6c ). Analysis of data obtained by RNA-based next-generation sequencing (RNA-Seq) did not reveal any substantial change in the expression of other H3K4-methylation enzymes in Mll4-KO cells ( Supplementary  Table 1 ), which suggested that the decrease in H3K4me1 at enhancers that were not directly bound by MLL4 was most probably caused by loss of MLL4 activity but not by the loss of other H3K4-methylation enzymes that resulted from the deletion of Mll4.
To investigate the effect of the deletion of Mll4 on transcription programs, we identified 576 genes and 430 genes whose expression was downregulated and upregulated, respectively, in the MLL4-deficient cells (data not shown). Gene-ontology-enrichment analysis revealed that the set of downregulated genes showed enrichment for genes encoding molecules with functions including lymphocyte activation, regulation of signal transduction, cytokine secretion, compared with the set of genes without a substantial change in expression, while the set of upregulated genes exhibited no obvious enrichment for any ontology term (Supplementary Table 2 ). Together our data suggested that MLL4 regulated H3K4me1 at enhancers by direct and/or indirect binding and contributed to the regulation of gene expression in naive CD4 + T cells.
MLL4 regulates H3K4me1 via chromatin interaction
The results reported above raised the possibility that monomethylation of H3K4 at MLL4-unbound regions might be catalyzed in trans by MLL4 bound at different sites via chromatin looping. To test this hypothesis, we analyzed genome-wide chromatin interactions in naive wild-type and Mll4-KO CD4 + T cells using the Hi-C chromosome-conformation-capture technique 29 (statistical analysis of Hi-C libraries, Supplementary Table 3 ). We defined a conservative set of H3K4me1-enriched regions that were not bound by MLL4 by calling A r t i c l e s MLL4 peaks using non-stringent thresholds with SICER 27 . On the other hand, we identified, with high confidence, a set of MLL4-bound regions using stringent thresholds with SICER 26 . We further identified interacting regions from Hi-C pair-end tags (PETs) by comparing those with a background model generated through simulation that considered GC content, mappability and distance. Substantial interactions were detected between the H3K4me1 peaks devoid of MLL4 binding and distant H3K4me1 peaks bound by MLL4, as exemplified by three putative enhancers upstream of the Cxcr4 locus ( Fig. 4d) . Approximately 8% of the MLL4-unbound H3K4me1 peaks were looped to distant MLL4-binding sites, which was fourfold higher than the expected frequency (Fig. 4e) . The fraction of MLL4unbound H3K4me1 peaks that showed a decrease in H3K4me1 after deletion of Mll4 was positively correlated with the number of interacting MLL4-binding sites, while the fraction that showed an increase in H3K4me1 was negatively correlated with it ( Fig. 4f) . Consistent with that, we found a greater decrease in H3K4me1 read density for MLL4-unbound enhancers that interacted with MLL4-binding sites than for those interacting with fewer or no MLL4-binding sites (Supplementary Fig. 6d ). The enrichment for H3K4me1 at MLL4unbound regions was positively associated with the aggregated MLL4 binding intensity from distantly interacting sites bound by MLL4 ( Fig. 4g) . Furthermore, MLL4-unbound sites with the most aggregated MLL4-binding intensity from distantly interacting sites showed the greatest decrease in H3K4me1 after deletion of Mll4 (Fig. 4h) .
Together these results supported the proposal that monomethylation of H3K4 at MLL4-unbound sites was catalyzed in trans by MLL4 bound to remote sites through chromatin looping ( Fig. 4i) . Therefore, we call the H3K4me1 peaks bound by MLL4' direct MLL4 targets' here and call the H3K4me1 peaks not bound by MLL4 but interacting with MLL4-bound regions 'indirect MLL4 targets' here.
MLL4 facilitates chromatin interactions at MLL4 targets
To investigate whether MLL4 contributed to interactions between regulatory sites in naive CD4 + T cells, we compared the chromatin-interaction density at direct and indirect MLL4 targets in wild-type cells with that in Mll4-KO cells. Deletion of Mll4 in naive CD4 + T cells substantially compromised chromatin interactions at many genomic loci, as exemplified by the Cxcr4 and Foxp3 loci ( Fig. 5a) . To detect genomewide changes, we divided the genome into 2-kb bins of equal size and assessed their change in interaction intensity with that of other genomic regions after deletion of Mll4. We found 23% of the direct MLL4 targets showed decreased interaction after deletion of Mll4, a proportion that was significantly greater than that of those showing increased interaction (4%) (Fig. 5b) . Notably, we also found that a significantly greater fraction of the indirect MLL4 targets showed decreased interaction (10%) than increased interaction (5%) after deletion of Mll4 (Fig. 5b) . In comparison, we observed no greater decrease than increase in interaction for the regions devoid of either direct or indirect MLL4 binding (Fig. 5b) . The interaction decrease caused by deletion of Mll4 was associated with a decrease in the active histone mark H3K27ac (Supplementary Fig. 6e,f) and an increase in the repressive histone mark H3K27me3 (Supplementary Fig. 6e,g) . Furthermore, the fraction of the direct MLL4 targets showing decreased interaction after deletion of Mll4 modestly correlated with MLL4 binding (Fig. 5c) . Notably, the fraction of the indirect A r t i c l e s MLL4 targets showing decreased interaction was highly correlated with the number of distantly interacting MLL4-bound sites (Fig. 5c) . Furthermore, the decrease in H3K4me1 at indirect MLL4 targets after deletion of Mll4 was associated with a decrease in interaction with remote MLL4-binding sites (Fig. 5d) . These results indicated that MLL4 promoted long-distance chromatin interactions at both direct MLL4 targets and indirect MLL4 targets.
MLL4 regulates enhancer-promoter interactions
Super-enhancers are regulatory elements critical for cell identity 30 . We identified 'regular' enhancers and super-enhancers in naive CD4 + T cells by ChIP-Seq analysis of H3K27ac ( Fig. 6a) and analyzed chromatin interactions at those elements in wild-type and Mll4-KO naive CD4 + T cells. Analysis of the chromatin-interaction data revealed that the 467 super-enhancers in naive CD4 + T cells were linked to genes encoding products important for T cell function and differentiation ( Fig. 6b) . To assess the function of MLL4 at enhancers, we divided non-promoter genomic regions into 2-kb bins and sorted them as regular enhancers, super-enhancers and other, non-enhancer regions (bins that did not overlap any enhancer). While only a few bins at non-enhancers were bound by MLL4, about half of the bins from super-enhancers and regular enhancers were bound by MLL4 ( Fig. 6c) . Meanwhile, 70% and 30% of MLL4-unbound bins within super-enhancers and regular enhancers, respectively, interacted with distant MLL4-bound regions ( Fig. 6c ) and thus could have been indirect targets of MLL4. Deletion of Mll4 resulted in significantly fewer chromatin interactions at 29% and 12% of the 2-kb bins within superenhancers and regular enhancers, respectively, while only 2% of the 2kb bins outside of enhancer regions exhibited fewer interactions after deletion of Mll4 (Fig. 6d) . Next we investigated whether the chromatin-interaction changes at regular and super-enhancers after deletion of Mll4 were related to the binding of MLL4. Genomic bins directly bound by MLL4 within super-enhancers exhibited the greatest decrease in chromatin interactions after deletion of Mll4 (30%) (Fig. 6e) . The bins next most affected were the 2-kb bins that interacted with distant MLL4-bound regions within super-enhancers (20%) (Fig. 6e) . The chromatin interactions at regular enhancers were similarly affected by deletion of Mll4 regardless of whether they were direct MLL4 targets or indirect MLL4 targets (Fig. 6e) . These results indicated that MLL4 contributed to the chromatin interaction of enhancers with the greatest effect on super-enhancers after deletion of Mll4.
To determine whether MLL4 contributed to specific promoterenhancer interactions, we analyzed interaction changes after deletion of Mll4 at promoters that were looped to super-enhancers (Pr-SE promoters) or regular enhancers (Pr-RE promoters) or were not looped to any enhancer (as a control). In general, we found that A r t i c l e s Pr-SE promoters showed the most significant decrease in chromatin interactions compared with that of the other promoters ( Fig. 6f and Supplementary Fig. 7a) ; we highlighted specific examples of super-enhancer targets for Cxcr4, Rac2 (which encodes the actin-remodeling GTPase Rac2) and Stk4 (which encodes the serine-threonine kinase Mst1) ( Supplementary Fig. 7b ). Furthermore, we found that deletion of Mll4 resulted in a greater decrease in Pr-SE and Pr-RE interactions than the decrease in interactions Control A r t i c l e s between the same promoters with non-enhancer regions (Fig. 6g) . In general, genes with the greatest decrease in interaction exhibited the greatest downregulation in expression in MLL4-deficient naive CD4 + T cells (Supplementary Fig. 7c ). Consistent with that, genes with promoters showing fewer interactions with enhancers or super-enhancers after deletion of Mll4 exhibited a general decrease in expression ( Fig. 6f,h and Supplementary Fig. 7d ), which indicated that direct binding of MLL4 and/or interaction with an MLL4-bound region facilitated promoter-enhancer interactions with a role in regulating gene expression.
MLL4 regulates H3K4me1 of Foxp3 via chromatin looping
To further understand how MLL4-dependent H3K4me1 and chromatin interactions between promoters and enhancers regulated T reg cell development, we focused our analysis on Foxp3 (ref. 4) , which is regulated by its promoter and several intronic enhancers 14, 31, 32 . We found neither the Foxp3 promoter nor its known enhancers exhibited MLL4 binding in naive CD4 + T cells (Fig. 7a) . Instead, strong MLL4 binding was detected at region 8.5 kb upstream of the Foxp3 transcription start site (called 'the −8.5 kb region' here) ( Fig. 7a) , which exhibited a general decrease in interaction with other genomic regions after deletion of Mll4 (data not shown). This MLL4-bound region interacted with the Foxp3 promoter and several H3K4me1-enriched regions not bound by MLL4, including the 3′ untranslated region and two regions 23 kb and 30 kb upstream of the Foxp3 transcription start site (Fig. 7a) . Deletion of Mll4 resulted in a substantial decrease in H3K4me1 at the Foxp3 promoter and at three putative enhancers not bound by MLL4 (Fig. 7a) , which suggested that binding of MLL4 at the −8.5 kb region regulated H3K4me1 at the Foxp3 promoter and several other putative enhancers through chromatin looping.
To determine whether binding of MLL4 at the −8.5 kb region regulated H3K4me1 at the Foxp3 promoter and other regions, we deleted this MLL4-binding site in mice by CRISPR technology 33 (called 'Foxp3 ∆MLL4BS ' here). We found that the CRISPR-mediated deletion (Fig. 7b) compromised H3K4me1 at four of the ten H3K4me1 peaks that interacted with the MLL4-binding site, including the Foxp3 promoter, in naive Foxp3 ∆MLL4BS CD4 + T cells (Fig. 7c) . In contrast, a significantly lower fraction of H3K4me1 peaks that did not interact with the MLL4 site from the same chromosome showed a decrease in H3K4me1 in these cells (Fig. 7d) .
To investigate whether that MLL4-binding site contributed to Foxp3 expression, we isolated naive CD4 + T cells from Foxp3 ∆MLL4BS mice and mice with an intact MLL4-binding site at the −8.5 kb region (called 'control mice' here) and stimulated them in iT reg cell-differentiating conditions. The induction of Foxp3 was compromised in cells from the Foxp3 ∆MLL4BS mice, as shown for mRNA ( Fig. 7e) and protein ( Fig. 7f,g) . To determine if the −8.5 kb region contributed to T reg cell development in vivo, we analyzed T reg cells in various organs of Foxp3 ∆MLL4BS mice. Although the reduction in the number of T reg cells in thymus was not reproducibly observed ( Fig. 7h,k) , we found modest but significant reduction in the number of Foxp3 + CD4 + T cells in spleen and lymph nodes in Foxp3 ∆MLL4BS mice compared with their abundance in the control mice (Fig. 7i,j,l,m) . T reg cells in Foxp3 ∆MLL4BS mice had a more activated phenotype than that of such cells from their control littermates, as defined by increased expression of Helios (Supplementary Fig. 8a-c) . The function of T reg cells in Foxp3 ∆MLL4BS mice remained unaffected, as cytokine production by T cells in the periphery of Foxp3 ∆MLL4BS mice was not greater than that of their counterparts in the control mice (Supplementary Fig. 8d-g) , and an in vitro suppression assay showed that Foxp3 ∆MLL4BS and control T reg cells had similar ability to suppress the proliferation of effector T cells (Supplementary Fig. 8h ). CD4 + CD25 + Foxp3thymocytes are considered precursors of mature T reg cells [34] [35] [36] . We observed significantly more of these precursors of T reg cells (Fig. 8a-d) and a lower intensity of Foxp3 staining in Foxp3 + thymic T reg cells in Foxp3 ∆MLL4BS mice and Mll4-KO mice than in control mice and wildtype mice, respectively (Fig. 8b,d) . Together these results suggested that binding of MLL4 at the −8.5 kb region regulated H3K4me1 at the A r t i c l e s DISCUSSION T cell differentiation is associated with dynamic changes in histone modifications 37 that are regulated by histone-modifying enzymes 38, 39 , suggestive of an important role for these enzymes in the development and differentiation of T cells. One major H3K4-methylation enzyme is MLL4, which regulates mainly H3K4me1 at enhancers 20 . By conditional deletion of Mll4 in CD4 + T cells, we found that MLL4 was a critical regulator of T reg cell development. However, deletion of Mll4 after the induction of Foxp3 did not alter the expression of Foxp3 in vitro or in vivo. Furthermore, in vitro T reg cell suppression assays revealed no difference in the suppressive ability of MLL4-deficient T reg cells relative to that of wild-type T reg cells. Consistent with that observation, Mll4 expression was rapidly downregulated after T reg cell differentiation in vitro. These results suggested that MLL4 was required for the establishment of chromatin structure in naive CD4 + T cells for future differentiation into the T reg cell lineage but was not required for either sustained Foxp3 expression or T reg cell activity. Although MLL4 might affect a cell population by regulating genes encoding products involved in the cell cycle 19 , our CFSE-staining experiments revealed that the proliferative capacity of Mll4-KO was similar to that of wild-type cells at day 4 of differentiation, which suggested that the developmental defect of T reg cells was caused by a specific effect of MLL4 on Foxp3 expression. Because MLL4 was not required for the maintenance of Foxp3 expression, we hypothesized that MLL4 functions to establish H3K4me1-modification patterns at the regulatory elements critical for the induction of Foxp3. Among the regulatory elements for Foxp3 expression 14, 40 , we found enrichment for H3K4me1 at the promoter region and CNS3 in naive CD4 + T cells, consistent with published studies 14 . Although MLL4 did not bind to any of those known Foxp3 regulatory elements, deletion of Mll4 compromised the H3K4me1 signals at the promoter and enhancer elements of Foxp3, which suggested that MLL4 might prime Foxp3 for activation under appropriate conditions by modulating the H3K4me1 signals at those regions in naive CD4 + T cells. Indeed, MLL4 might carry out this function by binding to the −8.5 kb region (upstream of the Foxp3 transcription start site). That region was looped to the promoter, CNS3 and 3′ untranslated region of Foxp3. CRISPR-mediated deletion of this region in Foxp3 ∆MLL4BS mice led to diminished H3K4me1 signals at the promoter and 3′ untranslated regions and resulted in a defect in the induction of Foxp3, which confirmed a regulatory role for this region for Foxp3 expression. Either deletion of Mll4 or CRISPR-mediated deletion of the MLL4-binding −8.5 kb region led to a significant increase in the CD4 + CD25 + Foxp3precursors of T reg cells, which provided further support for our hypothesis that MLL4 binds to the −8.5 kb region to prepare the enhancer landscape required for the efficient induction of Foxp3 during T reg cell development.
We found that only about half of the H3K4me1 peaks affected by deletion of Mll4 were bound by MLL4. Since no substantial changes in the expression of Mll3 or other histone methyltransfersases were detected in cells in which Mll4 was deleted, we hypothesized that MLL4 might bind to one site and catalyze the methylation of H3K4 at another remote site in trans by chromatin looping. Our data confirmed that the affected H3K4me1 peaks not bound by MLL4 were looped to chromatin regions directly bound by MLL4 and that the decrease in H3K4me1 was positively correlated to the number of loops between the unbound sites and MLL4-bound sites. That hypothesis was further confirmed by deletion of the MLL4-bound −8.5 kb region of Foxp3, which decreased H3K4me1 at the MLL4-unbound Foxp3 promoter and decreased the induction of Foxp3 under iT reg cell conditions. Thus, our data support the proposal of a mechanism in which, in addition to regulating H3K4me1 at direct binding sites, MLL4 also catalyzes in trans the monomethylation of H3K4 at unbound chromatin regions via chromatin looping to establish an enhancer landscape for cellular differentiation. Although we demonstrated this kind of activity only for MLL4 here, it is likely that a similar mechanism might be used by other chromatin-modifying enzymes within the nucleus.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS
Mice. Mll4 fl/fl mice on mixed C57BL/6 and 129 backgrounds were provided by K.G. and have been previously described 20 . Cd4-Cre + mice 41 on the C57BL/6 background were purchased from Taconic. Foxp3-CreYFP + mice 22 on the C57BL/6 background were purchased from Jackson Laboratories. Male and female mice were bred and maintained in an NHLBI specific-pathogen-free animal facility. All experiments were performed on 6-to 10-week-old mice in accordance with a protocol approved by the NHLBI Animal Care and Use Committee.
Cell isolation and in vitro culture. CD4 + T cells were purified from lymph nodes and spleen of Mll4 fl/fl Cd4-Cre -, Mll4 +/+ Cd4-Cre + , Mll4 fl/+ Cd4-Cre + and Mll4 fl/fl Cd4-Cre + mice by magnetic selection according to the protocol provided by the manufacturer (Miltenyi Biotech, CD4 + T Cell Isolation Kit, mouse). Naive CD4 + T cells were purified from the lymph nodes of Mll4 fl/fl Cd4-Cre -, Mll4 +/+ Cd4-Cre + , Mll4 fl/+ Cd4-Cre + and Mll4 fl/fl Cd4-Cre + mice, and control and Foxp3 ∆MLL4BS mice, by magnetic selection according to the protocol provided by the manufacturer (Miltenyi Biotech, CD4 + CD62L + T cell isolation kit II, mouse or Stem Cell, EasySep Mouse CD4 + CD62L + T cell Isolation Kit) or were sorted by flow cytometry on a FACSAria II cell analyzer (BD Biosciences) for CD4 + CD8 -CD62L + after pre-enrichment for CD4 + T cells by negative selection using MACS technology according to manufacturer's instructions (as described above). The purity of naive CD4 + T cells were assessed by flow cytometry for CD4 + , CD8and CD62L + on a FACSCanto II (BD Biosciences) and were analyzed in FlowJo software. Over 98% purity of CD4 + CD8 − CD62L + cells were considered for further experiments. Ex vivo T reg cells were purified from lymph nodes and spleen of Mll4 fl/fl Cd4-Creand Mll4 +/+ Cd4-Cre + mice by flow-cytometry sorting on a FACSAria II cell analyzer (BD Biosciences) for CD4 + CD8 − CD25 + after pre-enrichment for CD4 + T cells by negative selection using MACS technology (as described above) in accordance with the manufacturer's instructions. All antibodies used for sorting and flow-cytometry analyses were purchased from eBiosciences: anti-mouse CD4 (RM4-5), anti-mouse CD8 (53-6.7), anti-mouse CD4 (RM4-5) and antimouse CD62L (MEL-14). Dead cells were excluded by DAPI staining.
In vitro T reg cell differentiation and flow cytometry. Naive CD4 + T cells were incubated in T reg cell-differentiation condition in the presence of the following: plate-bound anti-CD3 (Clone: 145-2C11, 2 µg/ml, eBioscience), anti-CD28 (Clone: 37.51, 3 µg/ml, eBioscience), anti-IL-4 (10 µg/ml, BioXCell), anti-IFN-γ (Clone: R4-6A2, 10 µg/ml, BioXCell), anti-IL-12 (Clone: R1-5D9, 10 µg/ml, BioXcell), IL-2 (Cat# 212-12, 100 U/ml, Peprotech) and TGF-β (Cat# 240-B,5 ng/ml, R&D Systems). Cells were stained for surface markers with anti-mouse CD4 (RM4-5, eBioscience) and anti-mouse CD8 (53-6.7 eBiosciences). Intracellular staining was performed using Cytofix/Cytoperm buffer (eBioscience) to fix and permeabilize cells. Cells were then washed and stained with following antibodies: anti-mouse Helios (22F6, BioLegend), anti-mouse Ki67 (B56, BD Biosciences) and anti-mouse Foxp3 (FJK-16s, eBioscience). Dead cells were excluded from analysis using a LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Life Technologies). Sample were run on a FACSCanto II cell analyzer (BD Biosciences) and were analyzed with FlowJo software.
In vitro deletion of Mll4. A Cre-carrying, green fluorescent protein (GFP)expressing retroviral vector (pCre-GFP) was used for deletion of Mll4 from Mll4 fl/fl cells. The retroviral particles were packaged in 293T cells with the pEco packaging plasmid. Naive Mll4 fl/fl CD4 + T cells were cultured in T reg cell-differentiating conditions for 24 h. Cells were infected with fresh retrovirus expressing the empty vector (pRV-GFP) or Cre-carrying pCre-GTP on the second day of culture. Cells were cultured in T reg cell-differentiating conditions for additional 2 d. Then GFP + cells were sorted by flow cytometry on a FACSAria II cell sorter (BD Biosciences) and were analyzed for Foxp3 expression. The efficiency of transduction was 60-90%.
In vitro T reg cell-suppression assay. The in vitro suppression assay was performed as described previously 42 . In brief, CD4 + CD25 + T reg cells from the lymph nodes and spleen of wild-type and Mll4-KO mice and CD4 + CD25 − effector T cells (T eff cells) from wild-type mice were isolated by magnetic selection according to the protocol provided by the manufacturer (Miltenyi Biotech, CD4 + T Cell Isolation Kit, mouse) followed by flow-cytometry sorting on a FACSAria II (BD Biosciences) with following antibodies: anti-mouse CD4 (RM4-5; eBioscience) and anti-mouse CD25 (7D4, BD Biosciences). Prior to stimulation, CD4 + CD25 − T eff cells were stained with CFSE according to the manufacturer's instructions (ThermoFisher Scientific, CellTrace Violet Cell Proliferation Kit, for flow cytometry). CD4 + CD25 − T eff cells (4 × 10 4 per well) were then stimulated with 0.5 µg/ml soluble anti-CD3 (Clone: 145-2C11, eBioscience) and irradiated APCs (2 × 10 4 per well) in the presence or absence of freshly isolated CD4 + CD25 + T reg cells in U-bottomed 96-well plates. At day 3 of culture, the T eff cell proliferation was measured by flow cytometry as CFSE dilution and Foxp3 expression on FACSCanto II cell analyzer (BD Biosciences) and data were analyzed with FlowJo software. Antibody used for flow cytometry were as follows: anti-mouse CD4 (RM4-5; eBioscience) and anti-mouse Foxp3 (FJK-16s, eBioscience) . Dead cells were excluded from analysis using a LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Life Technologies).
Lamina propria lymphocytes preparation. Lamina propria lymphocytes (LPLs) were isolated and analyzed by flow cytometry as described previously 43 . In brief, small intestine without Peyer's patches was disrupted mechanistically. Segments of tissues were washed extensively, followed by incubation for 20 min at 37 °C with vigorous shacking in pre-warmed RPMI medium supplemented with 3% FBS, 5 mM EDTA and dithiothreitol at 0.145 mg/ml to remove intraepithelial lymphocytes. Next, the remaining tissues were digested with Liberase TL (Roche) at 0.2 mg/ml and 0.05% DNase (Sigma) in RPMI medium for 20 min at 37 °C with continuous stirring. Digested tissues were minced and passed through 70-and 40-µm cell strainers. Lymphocytes were enriched by Percoll density gradient centrifugation, and cell suspensions were resuspended and analyzed by flow cytometry.
Intracellular cytokine staining. IL-17A and IFN-γ cytokine expression was assessed by flow cytometry as described previously 43 . In brief, the cells were stimulated for 4 h in phorbol 1,2-myristate 1,3-acetate (5 ng/ml) and ionomycin (1 µg/ml) in the presence of the protein-transport inhibitor GolgiPlug (BD Pharmingen). Cells were stained for surface markers with following antibodies: anti-mouse TCRβ (H57-597; eBioscience), anti-mouse CD4 (RM4-5; eBioscience) and anti-mouse CD45 (30-F11, eBioscience). Cells were washed and fixed using Cytofix/Cytoperm buffer (BD Pharmingen or eBioscience). Intracellular staining was performed with following antibodies: anti-mouse IL-17a (TC11-18H10.1; BioLegend), anti-mouse IFN-γ (XMG1.2, eBiosciences), anti-mouse Foxp3 (FJK-16s, eBioscience) and anti-human/mouse T-bet (eBio4B10, eBiosciences). Dead cells were excluded from analysis using a Zombie Yellow Fixable Viability Kit (Biolegend) or a LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Life Technologies).
ChIP-seq.
ChIP-seq assays of naive CD4 + T cells were performed as described previously 44, 45 . In brief, cells for ChIP-seq were fixed for 10 min in 1% formaldehyde and sonicated and chromatin immunoprecipitation was performed with anti-MLL4 (refs. 19,20) , anti-H3K27ac (ab4729, Abcam; single experiment) and anti-H3K27me3 (07-449, Millipore). ChIP-seq for H3K4me1 was performed on native (not fixed) chromatin with anti-H3K4me1 (ab8895, Abcam). ChIP DNA was end-repaired using an End-It DNA End-Repair kit (Epicentre), and was indexed, amplified and sequenced on an Illumina 2G Genome Analyzer.
RNA-Seq.
RNA-Seq experiments were previously described 46 . Poly(A) RNA was isolated from naive CD4 + T cells and T reg cells with a Dynabeads mRNA Direct Kit (610.12, Invitrogen) following the protocol provided by the manufacturer. mRNA was reverse-transcribed with the use of Super Script Double-Stranded cDNA Synthesis Kit (Invitrogen) and Random Hexamer Primers (Invitrogen). Double-stranded cDNA was sonicated on Bioruptor (Diagenode), blunt-ended using an End-It DNA-Repair kit (Epicentre), indexed, amplified and sequenced on an Illumina 2G Genome Analyzer.
Immunoblot analysis. CD4 + T cells were lysed in RIPA buffer and proteins were resolved by the Novex NuPage SDS-PAGE gel system (Life Technologies). Proteins were transferred to Supported Nitrocellulose Membrane (Bio-Rad) and were incubated with anti-H3K4me1 (ab8895, Abcam), anti-H3K4me2 (ab32356, Abcam), anti-H3K4me3 (17-614, Millipore), anti-MLL4 (refs. 19,20) , anti-β-actin (clone: AC-15, Sigma-Aldrcih), anti-Rbbp5 Cat# A300-109A, BETHYL) and anti-panH3 (Cat# ab21054, Abcam) as a loading control. Blots were visualized with Pierce ECL Western Blotting Substrate (Thermo Scientific).
Modified Hi-C protocol. Naive CD4 + T cells were crossed linked with 1% formaldehyde for 10 min. Cells were lysed and digested with restriction enzymes CviQ I and CviA II and Bfa I for 20 min. The Hi-C samples were processed following the in situ Hi-C protocol 29 with modifications briefly described as follows: DNA ends were marked by biotin-14-dATP with Klenow (large) for 1 h at 37 °C. Blunt-ended DNA fragments were ligated with T4 DNA Ligase overnight at 16 °C. DNA was then reverse cross-linked and purified by phenol-chloroform extraction. Biotin was removed from unligated DNA ends by T4 DNA polymerase for 2 h at 12 °C. DNA was purified by phenolchloroform and sheared to 300-500 bp by sonication followed by DNA-end repair and the addition of adenosine residues 44 . Biotin-labeled DNA was precipitated by streptavidin beads, followed by Illumina adaptor ligation and PCR amplification. Hi-C experiments were done with n = 2 independent experiments for Mll4 -KO naive CD4 + T cells and n = 3 independent experiments for the control cells.
Deletion of the Foxp3 −8.5 kb MLL4-binding site using CRISPR-Cas9 technology. We used CRISPR-Cas9 technology to delete the putative 500bp MLL4-binding site at ~8.5 kb upstream of the Foxp3 transcription start site. To increase the chances of deletion, we designed two CRISPR single guide RNAs (sgRNAs) to cut each end of this 500-bp region. The sgRNAs for cutting the upstream end were 5′-GCCATGAGGATGTAGTCCAG-3′ and 5′-CTTCTGACCCTACCTGCCAA-3′, and the sgRNAs for cutting the downstream end were 5′-TGGACGGTACTGACCCCCGA-3′ and 5′-TGAAATGCAGGCGATTCTGG-3′. These four sgRNA target sequences were cloned by OriGene Technology into the pT7-Guide-IVT vector. Injectable sgRNAs were transcribed in vitro using a MEGAshortscript T7 Kit (Life Technologies), and the Cas9 mRNA was transcribed in vitro from plasmid MLM3613 (Addgene #42251) using a mMESSAGE mMACHINE T7 Kit (Life Technologies), as previously reported 33 . These four sgRNAs were co-injected with Cas9 mRNA into fertilized eggs collected from B6CBAF1/J mice (JAX) at a concentration of 100 ng/µl Cas9 mRNA and 20 ng/µl of each sgRNA. The injected zygotes were cultured overnight at 37 °C in a humidified incubator with 5% CO 2 . The next morning, those embryos that reached two-cell stage of development were implanted into the oviducts of pseudopregnant foster mothers. Offspring born to these foster mothers were genotyped by PCR amplification, followed by DNA sequencing. Data analysis. Definition of genomic regions. RefSeq gene annotation was downloaded from the UCSC genome browser. Promoters were defined as genomic regions spanning 2.5 kb upstream and downstream of annotated transcription start site. Gene-body regions were defined as starting from the transcription start site to the transcription end site, with the first 2.5 kb excluded. Other genomic regions are defined as intergenic. Regular active enhancers were estimated by H3K27ac peaks located beyond promoters and super-enhancers.
ChIP-Seq data analysis. All ChIP-Seq short reads were mapped to the mouse genome (mm9) by using Bowtie2 with default parameters 47 . Later analysis excluded short reads mapped to multiple genomic positions and kept only one read for each genomic site when it received multiple reads. ChIP-Seqread-enriched regions were identified with SICER with a window size of 200 bp and a gap size of 400 bp 26 . A conservative set of MLL4-binding sites were identified with stringent parameters and input control: E value = 1,000 and false-discovery rate (FDR) = 0.001. Here, 'E-value' refers to the number of expected peaks by assuming a random distribution of the ChIP-Seq reads 26 .
To have a conservative prediction on genomic regions that were not bound by MLL4, we increased the E-value for MLL4 peak call until the ChIP-Seq signal of the additionally called peaks was indistinguishable from the input signal ( Supplementary Fig. 5d ); for this purpose, non-stringent parameters were set: E value = 100,000 and FDR = 0.05. ChIP-Seq peaks for histone modifications H3K4me1, H3K27me3 and H3K27ac without inputs were called with an E-value of 10. Differential H3K4me1 peaks between deletion of Mll4 and control cells were predicted by EdgerR (FDR < 0.001; change of over twofold) 48 . The ROSE program 49 was applied to the H3K27ac ChIP-Seq data to identify super-enhancers in mouse naive CD4 + T cells with the "-t" option on to exclude the contribution of peaks from promoter regions.
RNA-Seq data analysis. The mRNA expression of a gene is quantified by RPKM (reads per kilobase of exon model per million reads) 50 with an inhouse script. The calculation of the change in gene expression ('fold' values) excluded genes that showed an RPKM less than one in both the Mll4-KO cells and wild-type cells. Differentially expressed genes were identified by a change in expression of >1.5-fold and an expression value of >3 for at least one of the two conditions: Mll4-KO and wild-type.
Hi-C data analysis. Pair-end short reads were mapped to the mouse genome (mm9) by Bowtie2 with default parameters 47 . In-house scripts were used to exclude pair-end tags-reads (PETs) with each end mapped to different chromosomes or showing low mapping quality (MAPQ < 10). For PETs mapped to the same positions, only one PET was kept.
To call intra-chromosomal interaction from Hi-C PETs, we divided the genome into bins of 1 kb and assessed the significance of interaction for bin pairs that were separated by at least L bps and were linked by at least n PETs using background models generated through simulation, which explicitly considered the number of total PETs, the distributions of GC content, mappability and distance from the observation. In brief, for each observed intra-chromosomal PET that linked two bins, we randomly assigned it to two bins from the same chromosome, but required that the GC contents from the new positions were similar to the original (with a fluctuation up to 2%); the mappability scores of the new bins were similar to those of the original (allowing a fluctuation up to 0.05); andthe distance between the two bins was the same as the original. The procedure was repeated for every intra-chromosomal PET such that the background shared the same number of PETs with the observation. To save computational time, we carried out the simulation on chromosome 1, and repeated it 5,000 times.
With the background models, we calculated the expected number of bin pairs linked by at least n PETs and separated by at least L bp and compared it to the observation. For example, the expected number of n = 4 under L = 11,000 was 3,608 for the Hi-C data generated for the control naive CD4 + T cells, and the observed number was 11,237, which corresponded to an enrichment ratio (Σ) of 3 = 11,237/3,608. We used the enrichment ratio as a threshold for an interaction call. As expected, a lower number of n was needed as L increased to achieve the same Σ. This led us to define a threshold step function that depended on distance L to ascertain the minimal number of PET n values required for a bin-pair interaction call under Σ = 3. An Σ of 3 meant that of three observations, one could be explained by the background model and was therefore probably a false-positive result, while the remaining two could not be explained that was and were therefore probably true positive results. In other words, an Σ of 3 corresponded to an estimated specificity of 67% ((Σ-1)/ Σ). We noticed that the Σ was underestimated for interaction calls made for functional genomic regions: we identified 12,413 interacted bin pairs bound by MLL4 and/or marked by H3K4me1 under Σ = 3 for chromosome 1, in contrast to 882 bin-pairs from the background model, which corresponded to an estimated specificity of 93%. The interaction among regulatory regions associated with H3K4me1 and/or MLL4 was the focus of this project.
To generate a BEDGraph presentation of interaction intensity of genomic bins, we considered PETs from interacted bins called under Σ = 3. For a given genomic bin of 1 kb, we estimated its interaction intensity by the number of PETs linked to any other interacted bins outsides this region, normalized by the total number of PETs from interacted bin pairs across the genome. To generate a smoothed view (for example, Fig. 5a ), we applied a sliding window of 10 bins at a step of one bin and averaged the interaction intensities of all bins within the window.
To call genomic regions with differential interaction between two conditions, we extended the bin size to 2 kb and counted the PETs that linked to any other interacted bins (Fig. 5b,c) or any other interacted bins with certain features (for example, overlapped with enhancers; Fig. 6d,e ) from the same chromosome for each condition. The EdgeR package 48 was applied to identify regions showing differential interaction in Mll4 -KO cells relative to that in wild-type cells (a change of over 1.5-fold and FDR < 0.05).
To investigate the relationship between the change in the abundance of H3K4me1 at MLL4-unbound genomic region and the change in interaction intensity with MLL4-bound remote sites (Fig. 5d) , we sorted the H3K4me1enriched regions on the basis of their response to the deletion of Mll4 in terms of the change in the abundance of H3K4me1. For each H3K4me1-enriched region, the numbers of PETs linking the region to interacted MLL4-binding sites were recorded for the cells in which Mll4 was deleted and wild-type cells and were transformed into a change in number ('fold' values). The distribution of that change was then compared among the three groups of H3K4me1enriched regions.
Gene-ontology-enrichment analysis. A gene was called a target of an enhancer if any 1-kb bin from the promoter of the gene interacted with any bin from the enhancer. Gene-ontology-enrichment analysis was carried out using the online DAVID Bioinformatics Resource 51 or GREAT 27 . Redundant GO terms from the DAVID output were removed by using REVIGO 52 .
Code availability. C++ code used to generate the step function for the identification of chromatin interaction from Hi-C PETs based on simulation is available on request.
Statistics.
We applied a two-sided Kolmogorov-Smirnov test (two-tailed throughout the manuscript) to assess the difference in the accumulated distribution of ChIP-Seq read density ( Fig. 4g and Supplementary Fig. 6b) , change in ChIP-Seq read density ('fold' values) ( Fig. 4h and Supplementary  Fig. 6d,f,g) , change in interaction intensity ('fold' values) ( Figs. 5d and 6f,g  and Supplementary Fig. 7a ) and change in gene expression ('fold' values) ( Fig. 6h and Supplementary Fig. 7c,d) for any two groups of interests. The Kolmogorov-Smirnov test is a nonparametric method that tests whether two probability distributions differ and requires no prior knowledge about the distributions 53 . In all the figures noted above (accumulative distribution), the vertical axis of the accumulative distribution of a measurement across a set refers to the frequency within the set with an amount less than the one specified in the horizontal axis. A line shift to the left side means a general lower amount in that measurement. The χ 2 test was used for comparison of two portions from independent samples, presented as a percentage (Figs. 5b and 7d) .
Statistical significance for other figures was calculated by the ANOVA test or Kruskal-Wallis when a sample did not meet Gaussian distribution assessed by the D' Agostino and Pearson omnibus normality test.
Data availability. The sequencing data including Hi-C, ChIP-Seq data and RNA-Seq have been deposited in the Gene Expression Omnibus database with accession number GSE69162. The source data of all figures that support the findings of this study are available from the corresponding author on request.
A Life Sciences Reporting Summary for this paper is available online. 
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